Thermo Fisher Scientific Inc (NYSE:TMO)
| 547.90 Delayed Data As of Jul 01 |  +4.62 / +0.85%Today’s Change | 497.83 Today|||52-Week Range 672.34 | -17.89% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Quarter Trend | |||||
|---|---|---|---|---|---|---|
| Quarter 3 2018 | Quarter 4 2018 | Quarter 1 2019 | Quarter 2 2019 | |||
| Operating Activities | Net Income / Starting Line | 709.0M | 898.0M | 815.0M | 1.1B | |
| Depreciation | 563.0M | 558.0M | 555.0M | 571.0M | ||
| Total Other Cash Flow | 60.0M | 73.0M | 62.0M | -423.0M | ||
| Funds From Operations | 1.1B | 1.5B | 1.3B | 981.0M | ||
| Funds From/For Other Operating Expenses | -106.0M | -334.0M | 677.0M | -313.0M | ||
| Net Cash Flow - Operating Activities | 1.2B | 1.8B | 649.0M | 1.3B | ||
| Investing | Capital Expenditures | -173.0M | -284.0M | -201.0M | -220.0M | |
| Fixed Asset Disposal | 3.0M | 44.0M | 6.0M | 1.1B | ||
| Net Assets From Acquisitions | 0.00 | -477.0M | -1.0M | -1.7B | ||
| Other Investing - Uses | 2.0M | -4.0M | 0.00 | 0.00 | ||
| Other Investing - Sources | 0.00 | 0.00 | 15.0M | 4.0M | ||
| Net Cash Flow Investing | -168.0M | -721.0M | -181.0M | -769.0M | ||
| Financing | Short Term Borrowings | -570.0M | 270.0M | -687.0M | 727.0M | |
| Long Term Borrowings | 690.0M | 0.00 | 0.00 | 0.00 | ||
| Long Term Debt Reduction | -695.0M | -4.0M | -1.0M | -2.0M | ||
| Net Proceeds Stock Sale | 19.0M | 39.0M | 81.0M | 41.0M | ||
| Common Preferred Redeemed | -250.0M | -250.0M | -750.0M | 0.00 | ||
| Common Dividends | -- | -- | -- | -- | -- | |
| Cash Dividends Paid - Total | -69.0M | -68.0M | -68.0M | -76.0M | ||
| Other Sources - Financing | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Other Uses - Financing | 1.0M | 0.00 | 0.00 | 0.00 | ||
| Net Cash Flow - Financing | -876.0M | -13.0M | -1.4B | 690.0M | ||
| Exchange Rate | Effect of Exchange Rate on Cash | -21.0M | -61.0M | -32.0M | -29.0M | |
| Net Change In Cash | 176.0M | 1.1B | -957.0M | 1.2B | ||
